These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

474 related articles for article (PubMed ID: 27688103)

  • 1. Oncologic outcomes and patient-reported quality of life in patients with oropharyngeal squamous cell carcinoma treated with definitive transoral robotic surgery versus definitive chemoradiation.
    Ling DC; Chapman BV; Kim J; Choby GW; Kabolizadeh P; Clump DA; Ferris RL; Kim S; Beriwal S; Heron DE; Duvvuri U
    Oral Oncol; 2016 Oct; 61():41-6. PubMed ID: 27688103
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The impact of transoral robotic surgery on the overall treatment of oropharyngeal cancer patients.
    Smith RV; Schiff BA; Garg M; Haigentz M
    Laryngoscope; 2015 Nov; 125 Suppl 10():S1-S15. PubMed ID: 26436491
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Utility of up-front transoral robotic surgery in tailoring adjuvant therapy.
    Gildener-Leapman N; Kim J; Abberbock S; Choby GW; Mandal R; Duvvuri U; Ferris RL; Kim S
    Head Neck; 2016 Aug; 38(8):1201-7. PubMed ID: 27225507
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Outcomes of transoral robotic surgery for early-stage oropharyngeal squamous cell carcinoma with low rates of adjuvant therapy: A consecutive single-institution study from 2013 to 2020.
    Meldgaard Justesen M; Kronberg Jakobsen K; Fenger Carlander AL; Hjordt Holm Larsen M; Wessel I; Kiss K; Friborg J; Ibrahim Channir H; Rubek N; Grønhøj C; von Buchwald C
    Oral Oncol; 2024 May; 152():106783. PubMed ID: 38569317
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Outcomes in surgically resectable oropharynx cancer treated with transoral robotic surgery versus definitive chemoradiation.
    Dhanireddy B; Burnett NP; Sanampudi S; Wooten CE; Slezak J; Shelton B; Shelton L; Shearer A; Arnold S; Kudrimoti M; Gal TJ
    Am J Otolaryngol; 2019; 40(5):673-677. PubMed ID: 31201038
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quality of life outcomes of transoral robotic surgery with or without adjuvant therapy for oropharyngeal cancer.
    Sethia R; Yumusakhuylu AC; Ozbay I; Diavolitsis V; Brown NV; Zhao S; Wei L; Old M; Agrawal A; Teknos TN; Ozer E
    Laryngoscope; 2018 Feb; 128(2):403-411. PubMed ID: 28771728
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Descriptive Study of Quality of Life Following Neoadjuvant Chemotherapy and Transoral Robotic Surgery for Human Papillomavirus-Associated Oropharyngeal Squamous Cell Carcinoma.
    Diaconescu A; Silver JA; Subramaniam T; Sewitch MJ; Mascarella MA; Ramirez-Garcia Luna J; Golabi N; Richardson K; Bouganim N; Forghani R; Marcin Mlynarek A; Hier MP; Sadeghi N
    J Otolaryngol Head Neck Surg; 2024; 53():19160216241248670. PubMed ID: 38888957
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Trans oral robotic surgery versus definitive chemoradiotherapy for oropharyngeal cancer: 10-year institutional experience.
    Meccariello G; Bianchi G; Calpona S; Parisi E; Cammaroto G; Iannella G; Sgarzani R; Montevecchi F; De Vito A; Capaccio P; Pelucchi S; Vicini C
    Oral Oncol; 2020 Nov; 110():104889. PubMed ID: 32653838
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical value of transoral robotic surgery: Nationwide results from the first 5 years of adoption.
    Li H; Torabi SJ; Park HS; Yarbrough WG; Mehra S; Choi R; Judson BL
    Laryngoscope; 2019 Aug; 129(8):1844-1855. PubMed ID: 30575965
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cost-Effectiveness Analysis of Chemoradiation Therapy Versus Transoral Robotic Surgery for Human Papillomavirus-Associated, Clinical N2 Oropharyngeal Cancer.
    Sher DJ; Fidler MJ; Tishler RB; Stenson K; al-Khudari S
    Int J Radiat Oncol Biol Phys; 2016 Mar; 94(3):512-22. PubMed ID: 26867880
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Utilization of Transoral Robotic Surgery (TORS) in patients with Oropharyngeal Squamous Cell Carcinoma and its impact on survival and use of chemotherapy.
    Baliga S; Kabarriti R; Jiang J; Mehta V; Guha C; Kalnicki S; Smith RV; Garg MK
    Oral Oncol; 2018 Nov; 86():75-80. PubMed ID: 30409323
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differences in Functional and Survival Outcomes Between Patients Receiving Primary Surgery vs Chemoradiation Therapy for Treatment of T1-T2 Oropharyngeal Squamous Cell Carcinoma.
    Amin DR; Philips R; Bertoni DG; Mastrolonardo EV; Campbell DJ; Agarwal AM; Tekumalla S; Urdang ZD; Luginbuhl AJ; Cognetti DM; Curry JM
    JAMA Otolaryngol Head Neck Surg; 2023 Nov; 149(11):980-986. PubMed ID: 37422846
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Minimally invasive surgery versus radiotherapy/chemoradiotherapy for small-volume primary oropharyngeal carcinoma.
    Howard J; Masterson L; Dwivedi RC; Riffat F; Benson R; Jefferies S; Jani P; Tysome JR; Nutting C
    Cochrane Database Syst Rev; 2016 Dec; 12(12):CD010963. PubMed ID: 27943254
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quality of life outcomes comparing primary Transoral Robotic Surgery (TORS) with primary radiotherapy for early-stage oropharyngeal squamous cell carcinoma: A systematic review and meta-analysis.
    Gupta KK; De M; Athanasiou T; Georgalas C; Garas G
    Eur J Surg Oncol; 2024 Jul; 50(7):108434. PubMed ID: 38795678
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transoral robotic surgery for oropharyngeal squamous cell carcinoma.
    Schmitt NC; Duvvuri U
    Curr Opin Otolaryngol Head Neck Surg; 2015 Apr; 23(2):127-31. PubMed ID: 25692632
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oncologic outcomes of transoral robotic surgery for HPV-negative oropharyngeal carcinomas.
    Parhar HS; Weinstein GS; O'Malley BW; Shimunov D; Rassekh CH; Chalian AA; Newman JG; Basu D; Cannady SB; Rajasekaran K; Lin A; Lukens JN; Swisher-McClure S; Cohen RB; Bauml JM; Aggrawal C; Brody RM
    Head Neck; 2021 Oct; 43(10):2923-2934. PubMed ID: 34101290
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Role of Transoral Robotic Surgery in the Management of HPV Negative Oropharyngeal Squamous Cell Carcinoma.
    Sload R; Silver N; Jawad BA; Gross ND
    Curr Oncol Rep; 2016 Sep; 18(9):53. PubMed ID: 27469262
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transoral robotic surgery alone for oropharyngeal cancer: quality-of-life outcomes.
    Choby GW; Kim J; Ling DC; Abberbock S; Mandal R; Kim S; Ferris RL; Duvvuri U
    JAMA Otolaryngol Head Neck Surg; 2015 Jun; 141(6):499-504. PubMed ID: 25834991
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oncological outcome following de-intensification of treatment for stage I and II HPV negative oropharyngeal cancers with transoral robotic surgery (TORS): A prospective trial.
    Dabas S; Gupta K; Ranjan R; Sharma AK; Shukla H; Dinesh A
    Oral Oncol; 2017 Jun; 69():80-83. PubMed ID: 28559025
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term survival outcomes after primary transoral robotic surgery (TORS) with concurrent neck dissection for early-stage oropharyngeal squamous cell carcinoma.
    Frederiksen JG; Channir HI; Larsen MHH; Christensen A; Friborg J; Charabi BW; Rubek N; von Buchwald C
    Acta Otolaryngol; 2021 Jul; 141(7):714-718. PubMed ID: 34191671
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.